NASDAQ: NKTR NEKTAR THERAPEUTICS 8-K

Nektar Therapeutics reports Q1 2026 financial results

Filed May 7, 2026 · Period ending May 7, 2026 · ~1 min read

Key Changes

  • high

    Nektar announced first quarter 2026 financial results via press release on May 7, 2026. Actual revenue, earnings, cash position, and pipeline updates are in the attached press release, not the 8-K itself.

  • medium

    This is a standard quarterly earnings disclosure. Investors should review the full press release (Exhibit 99.1) for financial details and any forward guidance provided by management.

    8-K: Earnings verify on EDGAR →

See the full narrative summary and section-by-section diff — create a free account to read more. Takes 30 seconds.

Partner

Trade NKTR commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Generated by AI · Jun 8, 2026 4:10 PM